selected publications
-
Quality of life and cost-effectiveness of convalescent plasma compared to standard care for hospitalized COVID-19 patients in the CONCOR-1 trial.
Transfusion.
2024
Academic Article
GET IT
Times cited: 4 - Correction to: Plasma extracellular vesicles and cell-free mitochondrial DNA are associated with cognitive dysfunction in treated older adults with HIV. 2023 GET IT
-
Plasma extracellular vesicles and cell-free mitochondrial DNA are associated with cognitive dysfunction in treated older adults with HIV.
Journal of neurovirology.
2023
Academic Article
GET IT
Times cited: 5 -
Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial.
2022
GET IT
Times cited: 2 -
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial.
Nature medicine.
2021
Academic Article
GET IT
Times cited: 219 -
Convalescent plasma for adults with acute COVID-19 respiratory illness (CONCOR-1): study protocol for an international, multicentre, randomized, open-label trial.
Trials.
2021
Academic Article
GET IT
Times cited: 18 - Elevated cardiac risk score by Atherosclerotic Cardiovascular Disease calculation is associated with albuminuria in older people living with HIV. AIDS (London, England). 2020 Academic Article GET IT